Companies and Institutions that are our partners:
Named after the year of the Great Chicago Fire and a tribute to the rebuilding and ingenuity it spurred, 1871 is located in the Merchandise Mart in Chicago and it aims to help Web innovation coalesce in this so-called Silicon Prairie in the city. Adding to the synergetic environs, 1871 community provides workspace for new companies willing to innovate in diverse digital sectors (from healthcare to finances and e-commerce) with seminars, mentorships and workshops for its members.1871 also envisions bringing in Venture Capital firms and Angel Investors to mingle with entrepreneurs looking for funding for their companies.
The Laboratory GENE - Center for Medical Genetics was established in 1982 in Belo Horizonte, Brazil when Dr. Sergio D. Pena, MD, Ph.D. returned to Brazil after 12 years of studies and research abroad (USA, Britain and Canada). The Laboratory conducts cytogenetic analysis, genetic tests, DNA paternity tests and genetic counseling for rare diseases with international quality standards.
Helixxa is the first company to provide genomic analysis services in Brazil and Latin America. Comprehensive services with high technology based on DNA and RNA analysis are provided. The mission of this company is to help people afford well-being and a better quality of life through excellence in technology and scientific knowledge applied to the most diverse fields such as agriculture, health, research, consumer goods and pharma.
Enzytec ia consulting company in Biotechnology that offers personalized services in Research & Development (R&D). This consulting company also provides technological guidance to other companies with specific commercial strategies in order to help launching new products in the market.
DataGenno is an interactive database containing molecular and clinical genetic information for health care professionals, research scientists and patients. A new search engine for information exchange between health care professionals and also a space for biotechnology and pharmaceutical companies to advertise new treatments and drugs to rare diseases.
Biodecade was founded by George S. Mack and he is an analyst and writer focusing on the field of molecular biology. Clientele include institutional investors, venture capitalists, intellectual property lawyers and C-level executives in the biotechnology and pharmaceutical industries.
Copyright, 2013 - Genomic Enterprise,
all rights reserved.